Benjamin F. Edwards & Company’s Acadia Pharmaceuticals ACAD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $17K | Buy |
1,012
+281
| +38% | +$4.72K | ﹤0.01% | 1582 |
|
|
2024
Q1 | $14K | Buy |
731
+131
| +22% | +$2.51K | ﹤0.01% | 1613 |
|
|
2023
Q4 | $19K | Hold |
600
| – | – | ﹤0.01% | 1493 |
|
|
2023
Q3 | $13K | Hold |
600
| – | – | ﹤0.01% | 1329 |
|
|
2023
Q2 | $14K | Hold |
600
| – | – | ﹤0.01% | 1344 |
|
|
2023
Q1 | $11K | Hold |
600
| – | – | ﹤0.01% | 1376 |
|
|
2022
Q4 | $10K | Hold |
600
| – | – | ﹤0.01% | 1416 |
|
|
2022
Q3 | $10K | Hold |
600
| – | – | ﹤0.01% | 1380 |
|
|
2022
Q2 | $8K | Hold |
600
| – | – | ﹤0.01% | 1414 |
|
|
2022
Q1 | $15K | Buy |
600
+300
| +100% | +$7.5K | ﹤0.01% | 1277 |
|
|
2021
Q4 | $7K | Hold |
300
| – | – | ﹤0.01% | 1445 |
|
|
2021
Q3 | $5K | Hold |
300
| – | – | ﹤0.01% | 1506 |
|
|
2021
Q2 | $7K | Hold |
300
| – | – | ﹤0.01% | 1440 |
|
|
2021
Q1 | $8K | Buy |
300
+100
| +50% | +$2.67K | ﹤0.01% | 1400 |
|
|
2020
Q4 | $11K | Buy |
+200
| New | +$11K | ﹤0.01% | 1260 |
|